“…Additionally, low miR-26a plasma level is highly correlated with certain markers (e.g., CK-MB and troponin I) in STEMI patients ( Chiang et al, 2020 ), and immunoreactivity of Nε-(carboxymethyl)lysine is positively correlated with NT-proBNP and cardiac fibrosis ( Nogami et al, 2020 ). Furthermore, abnormal myocardial collagen I and III release certain peptides in the circulation as fibrotic markers ( Nikolov and Popovski, 2022 ), such as PICP and PIIINP, directly correlating with indexes of cardiac diastolic function ( Osokina et al, 2020 ). Furthermore, serum PIIINP of ≥381.4 ng/ml on the 12th day increases the risk of cardiac fibrosis 1 year after the disease onset in STEMI patients with preserved ejection fraction (EF) of I–III degree ( Osokina et al, 2021 ).…”